1. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. Issue 2 (1st February 2017) Authors: Pautier, Patricia; Vergote, Ignace; Joly, Florence; Melichar, Bohuslav; Kutarska, Elzbieta; Hall, Geoffrey; Lisyanskaya, Anna; Reed, Nicholas; Oaknin, Ana; Ostapenko, Valerijus; Zvirbule, Zanete; Chetaille, Eric; Geniaux, Agnès; Shoaib, Muhammad; Green, John A. Journal: International journal of gynecological cancer Issue: Volume 27:Issue 2(2017) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. Issue 2 (February 2017) Authors: Pautier, Patricia; Vergote, Ignace; Joly, Florence; Melichar, Bohuslav; Kutarska, Elzbieta; Hall, Geoffrey; Lisyanskaya, Anna; Reed, Nicholas; Oaknin, Ana; Ostapenko, Valerijus; Zvirbule, Zanete; Chetaille, Eric; Geniaux, Agnès; Shoaib, Muhammad; Green, John A. Journal: International journal of gynecological cancer Issue: Volume 27:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗